Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Choosing PET over SPECT | Key M&A trends in cardiology | Rising healthcare costs | Surgical backup during TAVR: Is it necessary?
Monday, October 26, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Policy & Regulations

Safer, faster, more effective: Why cardiac PET should be the primary nuclear modality

Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.

READ MORE >
Rick Snyder, MD, FACC, president of the Cardiac PET Alliance, president of HeartPlace and chief physician executive at U.S. Heart and Vascular, spoke with Cardiovascular Business in the above video interview. He said the organization is working with lawmakers and healthcare systems to expand access to cardiac PET. The effort also aims to educate government and commercial payers about the technology's potential to improve patient care while reducing overall healthcare costs.
Share on Twitter Share on Facebook Share on Linkedin

Safer, faster, more effective: Why cardiac PET should be the primary nuclear modality

Share on Twitter Share on Facebook Share on Linkedin
Rick Snyder, MD, FACC, president of the Cardiac PET Alliance, president of HeartPlace and chief physician executive at U.S. Heart and Vascular, spoke with Cardiovascular Business in the above video interview. He said the organization is working with lawmakers and healthcare systems to expand access to cardiac PET. The effort also aims to educate government and commercial payers about the technology's potential to improve patient care while reducing overall healthcare costs.
Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.
READ MORE >

What private practices, hospitals and investors should know about the M&A market in cardiology

William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 

READ MORE >
business people
Share on Twitter Share on Facebook Share on Linkedin

What private practices, hospitals and investors should know about the M&A market in cardiology

Share on Twitter Share on Facebook Share on Linkedin
business people
William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 
READ MORE >

Policy expert explains why cardiology services in the US are getting more expensive

"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

READ MORE >
Video: Rick Snyder, MD, FACC, president of HeartPlace, and Chief Physician Executive at U.S. Heart and Vascular, testified to Congressional leaders in his role with the American Independent Medical Practice Association (AIMPA) to explain how federal healthcare policies have created an inefficient payment system that rewards higher cost care models and is putting lower cost private practices out of business.
Share on Twitter Share on Facebook Share on Linkedin

Policy expert explains why cardiology services in the US are getting more expensive

Share on Twitter Share on Facebook Share on Linkedin
Video: Rick Snyder, MD, FACC, president of HeartPlace, and Chief Physician Executive at U.S. Heart and Vascular, testified to Congressional leaders in his role with the American Independent Medical Practice Association (AIMPA) to explain how federal healthcare policies have created an inefficient payment system that rewards higher cost care models and is putting lower cost private practices out of business.
"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.
READ MORE >

Is surgical backup still necessary during TAVR? Opinions are mixed as bailout risk decreases

Surgical bailout during TAVR is growing increasingly rare as time goes on. Does that mean it is time to rethink certain coverage policies? A new study and two separate editorials examined this topic in great detail.

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Is surgical backup still necessary during TAVR? Opinions are mixed as bailout risk decreases

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Surgical bailout during TAVR is growing increasingly rare as time goes on. Does that mean it is time to rethink certain coverage policies? A new study and two separate editorials examined this topic in great detail.
READ MORE >

FDA shares warning about Edwards Lifesciences heart valve tech after patient death

Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. 

READ MORE >
alert FDA recall safety warning
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about Edwards Lifesciences heart valve tech after patient death

Share on Twitter Share on Facebook Share on Linkedin
alert FDA recall safety warning
Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. 
READ MORE >

CMS considers covering TAVR for aortic regurgitation

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS considers covering TAVR for aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 
READ MORE >

Physicians support Medicare coverage for TAVR in patients with aortic regurgitation

The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Physicians support Medicare coverage for TAVR in patients with aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.
READ MORE >

Abbott updates heart device instructions to highlight safety risk

The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned.

READ MORE >
Physician warning
Share on Twitter Share on Facebook Share on Linkedin

Abbott updates heart device instructions to highlight safety risk

Share on Twitter Share on Facebook Share on Linkedin
Physician warning
The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned.
READ MORE >

FDA shares draft guidance for cardiovascular surgical robots

The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It covers robotic systems of all types, including those used for various cardiac procedures. 

READ MORE >
The DaVinci robotic surgical system has been very successful in expanding the adoption of less invasive robotic surgical techniques. The FDA is now developing new standards for how it will review these systems as more come up for regulatory review.
Share on Twitter Share on Facebook Share on Linkedin

FDA shares draft guidance for cardiovascular surgical robots

Share on Twitter Share on Facebook Share on Linkedin
The DaVinci robotic surgical system has been very successful in expanding the adoption of less invasive robotic surgical techniques. The FDA is now developing new standards for how it will review these systems as more come up for regulatory review.
The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It covers robotic systems of all types, including those used for various cardiac procedures. 
READ MORE >

Thousands of New York heart patients may lose access to care—state senator asks governor to intervene

Cardiology services for approximately 50,000 patients are in the middle of an ongoing legal battle. New York Sen. Jim Tedisco is now publicly calling for New York. Gov. Kathy Hochul to step in and help. 

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

Thousands of New York heart patients may lose access to care—state senator asks governor to intervene

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Cardiology services for approximately 50,000 patients are in the middle of an ongoing legal battle. New York Sen. Jim Tedisco is now publicly calling for New York. Gov. Kathy Hochul to step in and help. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup